<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-US">
	<id>https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3AMarket_value_margin_%28MVM%29</id>
	<title>Definition:Market value margin (MVM) - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3AMarket_value_margin_%28MVM%29"/>
	<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Market_value_margin_(MVM)&amp;action=history"/>
	<updated>2026-05-01T05:09:42Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://www.insurerbrain.com/w/index.php?title=Definition:Market_value_margin_(MVM)&amp;diff=19297&amp;oldid=prev</id>
		<title>PlumBot: Bot: Creating new article from JSON</title>
		<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Market_value_margin_(MVM)&amp;diff=19297&amp;oldid=prev"/>
		<updated>2026-03-16T11:31:23Z</updated>

		<summary type="html">&lt;p&gt;Bot: Creating new article from JSON&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;📊 &amp;#039;&amp;#039;&amp;#039;Market value margin (MVM)&amp;#039;&amp;#039;&amp;#039; is a component of [[Definition:Technical provisions | technical provisions]] under certain [[Definition:Solvency | solvency]] frameworks that represents the additional cost a third party would demand, above the [[Definition:Best estimate liability (BEL) | best estimate liability]], to assume an insurer&amp;#039;s insurance obligations. The concept reflects the idea that a willing buyer of a portfolio of insurance liabilities would require compensation for the uncertainty and [[Definition:Non-hedgeable risk | non-hedgeable risks]] embedded in those obligations — risks that cannot be fully eliminated through [[Definition:Reinsurance | reinsurance]] or financial instruments. Under [[Definition:Solvency II | Solvency II]] in the European Union, this margin is formally termed the [[Definition:Risk margin | risk margin]] and is calculated using a [[Definition:Cost of capital method | cost-of-capital approach]], while the Swiss Solvency Test (SST) employs a conceptually similar market value margin. The terminology and precise methodology differ across jurisdictions, but the underlying principle — that [[Definition:Technical provisions | technical provisions]] should approximate a transfer value rather than just an actuarial best estimate — is shared across modern risk-based regimes.&lt;br /&gt;
&lt;br /&gt;
⚙️ The standard calculation projects the future [[Definition:Solvency capital requirement (SCR) | solvency capital requirement]] for non-hedgeable risks over the full run-off period of the liabilities, then applies a prescribed cost-of-capital rate to each year&amp;#039;s projected capital charge and discounts the resulting stream back to the valuation date. Under Solvency II, the cost-of-capital rate is set at six percent, a parameter that has attracted sustained debate about whether it overstates the true market price of bearing insurance risk. Because projecting future [[Definition:SCR | SCR]] figures year by year is computationally intensive — particularly for long-duration [[Definition:Life insurance | life insurance]] and [[Definition:Annuity | annuity]] portfolios — regulators permit simplified methods, including proportional approximations that scale the margin from a single valuation-date SCR. The resulting MVM is added to the [[Definition:Best estimate liability (BEL) | best estimate liability]] to form the total technical provisions on the [[Definition:Balance sheet | balance sheet]], directly influencing an insurer&amp;#039;s [[Definition:Own funds | own funds]] and solvency ratio.&lt;br /&gt;
&lt;br /&gt;
💡 For long-tail lines such as [[Definition:Pension | pension]] annuities or [[Definition:Disability insurance | disability]] covers, the MVM can be material — sometimes rivaling or exceeding the present value of future profits on a book of business. This has tangible strategic consequences: it can discourage insurers from writing very long-duration products, since the solvency cost of holding the margin erodes returns on capital. The 2019 Solvency II review and the UK&amp;#039;s subsequent post-Brexit reforms under the [[Definition:Solvency UK | Solvency UK]] initiative specifically targeted the risk margin calibration, with the UK ultimately adopting a modified methodology that tapers the margin for long-dated liabilities. Across markets, the treatment of this margin remains one of the most consequential technical choices in insurance regulation, shaping [[Definition:Product pricing | product pricing]], [[Definition:Capital management | capital management]], and the competitive dynamics between jurisdictions.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Related concepts:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
{{Div col|colwidth=20em}}&lt;br /&gt;
* [[Definition:Risk margin]]&lt;br /&gt;
* [[Definition:Best estimate liability (BEL)]]&lt;br /&gt;
* [[Definition:Solvency capital requirement (SCR)]]&lt;br /&gt;
* [[Definition:Technical provisions]]&lt;br /&gt;
* [[Definition:Cost of capital method]]&lt;br /&gt;
* [[Definition:Solvency II]]&lt;br /&gt;
{{Div col end}}&lt;/div&gt;</summary>
		<author><name>PlumBot</name></author>
	</entry>
</feed>